| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 11/11/2008 | US7449608 Naphthol derivative and charge control agent comprising the same |
| 11/11/2008 | US7449599 Phenyl carboxamide compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 11/06/2008 | WO2008131972A1 Arylmethylen substituted n-acyl-gamma-aminoalcohols |
| 11/06/2008 | WO2008030883A3 Treatment of cancer |
| 11/06/2008 | US20080275100 For inducing general anesthesia, sedation, and/or hypnotic or sleep effects in patient |
| 11/06/2008 | US20080275047 Tetrahydro-naphthalene derivatives |
| 11/05/2008 | EP1270545B1 Process for producing amine derivatives |
| 11/05/2008 | CN101300005A N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 11/04/2008 | US7446222 2-benzyloxy-5-chloro-[1,1';2',1'']terphenyl-3''-carboxylic acid; neuropathic pain; chronic articular pain (e.g. rheumatoid arthritis, osteoarthritis, rheumatoid spondylitis, gouty arthritis and juvenile arthritis) including the property of disease modification and joint structure preservation |
| 10/30/2008 | WO2008130508A1 Indanone derivatives that inhibit prolyl hydroxylase |
| 10/30/2008 | WO2008130319A2 Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain |
| 10/30/2008 | US20080269333 Anthranilic acid derivatives useful in treating infection with hepatitis c virus |
| 10/30/2008 | US20080269296 Diaryl ethers as opioid receptor antagonists |
| 10/30/2008 | US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease |
| 10/30/2008 | US20080269166 O-desmethylvenlafaxine succinate; tablet, capsule; sustained release; hydroxypropylmethyl cellulose rate controlling polymer; microcrystalline cellulose binder; depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease |
| 10/30/2008 | US20080269134 Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
| 10/29/2008 | EP1985612A1 Arymethylen substituted N-Acyl-gamma-aminoalcohols |
| 10/29/2008 | EP1513892B1 Conversion products of mixtures of long-chained fatty acids and aliphatic diamines, and the use thereof |
| 10/29/2008 | EP1419138B1 N- (1-dimethylaminocycloalkyl)methyl benzamide derivatives |
| 10/29/2008 | CN101293854A Novel midbody of pemetrexed, preparing method and application thereof |
| 10/29/2008 | CN101293853A Cation fluorine surfactant and preparation method thereof |
| 10/29/2008 | CN101293852A Metal plating compositions and methods |
| 10/28/2008 | USRE40558 Peroxisome proliferator-activated receptors agonists/ antagonists; 2-methyl-6-[3-(quinolin-2-ylmethoxy)-propoxymethyl]-benzoic acid; eating diorders; physiological detrimental blood level of insulin, glucose, free fatty acids, or triglycerides; hyperlipemia; atherosclerosis; antidiabetic agent |
| 10/28/2008 | US7442830 Proteasome inhibitors |
| 10/28/2008 | US7442558 Phthalamide-lanthanide complexes for use as luminescent markers |
| 10/28/2008 | CA2230921C Process for the purification of diphenyl ether compounds |
| 10/28/2008 | CA2229735C Process for nitrating diphenyl ether compounds |
| 10/23/2008 | WO2008128207A1 Alpha-galactosyl ceramide analogs and their use as immunotherapies |
| 10/23/2008 | WO2008126731A1 Aryl derivatives |
| 10/23/2008 | US20080262011 N-(2-hydroxy-1-methyl-ethyl)-3-iodobenzamide; for the treatment of a muscular disorder, a gastrointestinal disorder, or for controlling spasticity or tremors; modulates cannabinoid receptors |
| 10/23/2008 | CA2683681A1 Alpha-galactosyl ceramide analogs and their use as immunotherapies |
| 10/22/2008 | EP1981838A2 Process for synthesis of glycomimicking cationic amphiphiles |
| 10/22/2008 | EP1981837A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
| 10/21/2008 | US7439394 Cyclohexyl-1,4-diamine compounds |
| 10/21/2008 | US7439383 Sodium channel blockers |
| 10/21/2008 | US7439366 Phenacylamine derivatives, process for their production and pesticides containing them |
| 10/21/2008 | US7439358 Specific salt, anhydrous and crystalline form of a dihydropteridione derivative |
| 10/16/2008 | WO2008057862A3 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF |
| 10/16/2008 | US20080255182 Certain chemical entities, compositions, and methods |
| 10/16/2008 | US20080255152 Diaryl ethers as opioid receptor antagonists |
| 10/15/2008 | EP1308436B1 Calcium receptor antagonists |
| 10/15/2008 | CN101284865A New compound and its medicine use |
| 10/15/2008 | CN101284799A Nitrogen-contained derivates of caffeoylquinic acid, method for preparing same, pharmaceutical compositions thereof and uses |
| 10/14/2008 | US7435850 2-Fluoro-N-[3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]acetamide, its enantiomers, and addition salts; melatoninergic disorders, circadian rhythm disorders, antidepressants, seasonal affective disorders, sleep disorders, jetlag |
| 10/09/2008 | WO2008073390A3 Preparation of 3,4-dihydroisoquinolines from an acid and an amine |
| 10/09/2008 | US20080249318 Splitting of the corresponding phenylindole compound containing lactam group; cyclooxygenase inhibitor |
| 10/09/2008 | US20080249137 e.g. {3-butoxy-5-[4-(4-trifluoromethoxy-phenoxy)-benzenesulfonyl]-phenyl}-acetic acid; peroxisome proliferator activated receptor modulator; antidiabetic agent; obesity, hyperlipidemia, dyslipidemia, hypertriglyceridemia, Syndrome X, insulin resistance, diabetic neuropathy, atherosclerosis, eczema |
| 10/09/2008 | US20080249107 Comprising trihydroxy phenyl subunits; selectin inhibitors; side effect reduction; 3-{3-[3-(3,4,5-Trihydroxy-phenyl)-propionylamino]-phenylamino}-benzoic acid |
| 10/08/2008 | EP1976823A1 Dibenzene derivatives as calcium channel blockers |
| 10/08/2008 | EP1523469B1 Cinnamide derivatives |
| 10/08/2008 | CN101279928A N-methyl-2-[4-(4í»-chlorophenoxy) phenoxy]acetamide and preparation thereof |
| 10/07/2008 | US7432396 Process for producing (Z)-1-phenyl-1-diethylaminocarbonyl-2-hydroxymethylcyclopropane |
| 10/07/2008 | US7432389 Inhibiting beta-secretase enzyme activity and A beta peptide production, to reduce amyloid beta deposits or plaques |
| 10/07/2008 | US7432240 Fumaric acid amides |
| 10/02/2008 | WO2008118315A1 Process for making an acrylic monomer having one or more quaternary ammonium groups and its polymers |
| 10/02/2008 | WO2008116385A1 Caffeoyl quinic acid derivatives containing nitrogen, and preparation method, pharmaceutically composition and usage thereof |
| 10/01/2008 | EP1975149A1 1,3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof |
| 10/01/2008 | EP1672055B1 Detergent compositions and processes for the production thereof |
| 10/01/2008 | CN101277931A Synthetic processes for the preparation of aminocyclohexyl ether compounds |
| 09/30/2008 | US7429677 3'-methylene-bis(6-((4-methylphenyl)sulfonylamino)-benzoic acid) , or its N-oxide form, salt, stereoisomeric form, racemic mixture, prodrug or ester; block HIV from entering the human cell by interfering with various phases of attachment and fusion between HIV and the cell; Anti HIV agent; AIDS |
| 09/30/2008 | US7429673 TRPV1 agonists, formulations containing them and uses thereof |
| 09/30/2008 | US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 09/25/2008 | US20080234508 Process for the Preparation of N(5)-Ethylglutamine |
| 09/25/2008 | US20080234320 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 09/25/2008 | US20080234199 Chemical Compounds |
| 09/24/2008 | EP1831152B1 Tetralin and indane derivatives and uses thereof as 5-ht antagonists |
| 09/23/2008 | CA2378795C High selective herbicidal phenoxypropionic acid alkoxycarbonyl anilid compounds and method of preparing thereof |
| 09/23/2008 | CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof |
| 09/18/2008 | WO2008112836A2 Pharmaceutical composition comprising human growth hormon |
| 09/18/2008 | US20080227859 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 09/17/2008 | EP1969129A1 Method for producing (r) - and (s)-4-(1-ammoniumethyl)benzoic acid methylester-sulphate from racemic 4-(1-aminoethyl)benzoic acid methylester by lipase catalysed enantoselective acylation and subsequent precipitation with sulphuric acid |
| 09/17/2008 | EP1968935A1 Substituted bis(hetero)aromatic n-ethylpropiolamides and use thereof for production of medicaments |
| 09/17/2008 | EP1968933A1 Process for the preparation of 2-chloroethoxy-acetic acid-n,n-dimethylamide |
| 09/17/2008 | CN101268062A 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the GABA-B-receptor |
| 09/17/2008 | CN101268039A Novel carboxylic acid derivatives |
| 09/17/2008 | CN101265226A Compounds and methods for delivery of prostacyclin analogs |
| 09/16/2008 | CA2515338C Inhibitors of histone deacetylase |
| 09/11/2008 | US20080221210 3-(3,5-dibromo-4-{[3-(methylamino)benzyl]oxy}phenyl)propanoic acid; hypercholesterolemia, dyslipidemia, obesity, diabetes, atherosclerosis and cardiac diseases |
| 09/11/2008 | US20080217580 Organic Luminescent Element |
| 09/10/2008 | EP1966181A2 Anthranilic acid derivatives useful in treating infection with hepatitis c virus |
| 09/10/2008 | EP1285908B1 Substituted phenylpropionic acid derivatives |
| 09/09/2008 | US7423177 Carboxamide derivatives as therapeutic agents |
| 09/09/2008 | US7423154 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates |
| 09/09/2008 | US7423067 Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists |
| 09/09/2008 | CA2366205C Biphenyl derivatives |
| 09/04/2008 | WO2008106179A1 Intermediates and processes for the synthesis of ramelteon |
| 09/04/2008 | WO2008105538A1 Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystal polymer and optically anisotropic substance |
| 09/04/2008 | WO2007117544A3 Carnitine conjugates of adamantanamines and neramexane derivatives as duel prodrugs for various uses |
| 09/04/2008 | WO2007054776A3 Stilbene like compounds as novel hdac inhibitors |
| 09/04/2008 | US20080214869 Processes for purification of tigecycline |
| 09/04/2008 | US20080214673 e.g. Furan-3-carboxylic acid [(1R,3R)-3-(3-chloro-phenylethynyl)-3-hydroxy-cyclohexyl]-amide; metabotropic glutamate receptors modulator/antagonist;anxiolytic agent, antidepressant; amidation of amine-compounds |
| 09/04/2008 | US20080214638 To treat diseases of lipid metabolism, cardiovascular disease, inflammatory diseases; selective agonists of the nicotinic acid receptor; 2-{[(4-Biphenylyloxy)acetyl]amino}-4-(methyloxy)benzoic acid |
| 09/04/2008 | US20080214609 compounds that agonize the membrane-associated estrogen receptor identified herein act as neuroprotectants to reduce neuronal cell death in response to ischemic stroke and inhibit reperfusion injury |
| 09/04/2008 | US20080213347 Novel ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof |
| 09/03/2008 | CN100415750C Fungicides for the control of take-all disease of plants |
| 09/02/2008 | US7420090 Fungicides |
| 09/02/2008 | US7420085 Form II; used for facilitating the delivery of active agents, such as insulin, to a target |
| 09/02/2008 | US7420078 Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3,5-dihydroxy heptanoic acid derivatives, and intermediates thereof |
| 08/28/2008 | WO2008103141A1 Shea butter dimethyl amidopropyl amines |
| 08/28/2008 | US20080207753 Antiinflammatory agents; cardiovascular disorders; vision defects; skin disorders; central nervous system disorders; antiarthritic agents |